| Groups | Statistics |
---|
| no-BED/FA (n = 80) | BED (n = 43) | FA (n = 24) | BED-FA (n = 53) | F/χ2 | p | ŋ2 | Bonferroni post-hoc |
---|
Age† | 41.1 (11.9) | 36.5 (12.6) | 43 (11.8) | 39.6 (13.4) | 1.825 | ns | | |
Sex (f)‡ | 58 (72.5) | 39 (90.7) | 18 (75) | 48 (90.6) | 10.272 | .016 | | |
BMI† | 40.7 (7.5) | 40.6 (7.6) | 42.7 (8.4) | 41.7 (7.6) | 0.599 | ns | | |
BES | | | | | | 196.296 | < .001 | | |
| Mild | 80 (100) | – | 24 (100) | – | | | | |
| Moderate | – | 13 (30.2) | – | 15 (28.3) | | | | |
| Severe | – | 30 (69.8) | – | 38 (71.7) | | | | |
YFAS 2.0 | | | | | | 232.503 | < .001 | | |
| None | 80 (100) | 43 (100) | – | – | | | | |
| Mild | – | – | 7 (29.2) | 2 (3.8) | | | | |
| Moderate | – | – | 10 (41.6) | 16 (30.2) | | | | |
| Severe | – | – | 7 (29.2) | 35 (66.0) | | | | |
FPG†a | 90.0 (10.4) | 88.1 (12.2) | 88.7 (10.0) | 91.0 (10.8) | 4.365 | .006 | 0.096 | BED-FA > FA, BED |
FPI†b | 18.4 (8.7) | 19.9 (11.3) | 17.5 (6.8) | 19.3 (10.5) | 4.296 | .007 | 0.094 | BED, BED-FA > OB, FA |
Matsuda index†c | 2.5 (1.2) | 3.1 (1.7) | 2.4 (1.3) | 2.4 (1.3) | | ns | | |
HOMA-IR†d | 4.1 (2.0) | 4.5 (3.2) | 3.8 (1.5) | 4.4 (2.7) | 6.386 | < .001 | 0.134 | BED, BED-FA > OB, FA |
logIGI†e | 1.5 (0.3) | 1.5 (0.4) | 1.4 (0.3) | 1.4 (0.3) | | ns | | |
GTP‡ | | | | | 22.090 | .009 | | |
| NGT | 49 (61.3) | 32 (74.4) | 11 (45.8) | 38 (71.7) | | | | |
| IFG | 4 (5.0) | 5 (11.6) | – | 1 (1.9) | | | | |
| IGT | 18 (22.4) | 3 (7.0) | 10 (41.7) | 6 (11.3) | | | | |
| IFG + IGT | 9 (11.3) | 3 (7.0) | 3 (12.5) | 8 (15.1) | | | | |
- Bold; significant p-value after Bonferroni correction for multiple comparisons (set at p < .01)
- BED: binge eating disorder; FA: food addiction; BMI: body mass index; BES: binge eating scale; YFAS: yale food addiction scale; FPG: fasting plasma glucose; FPI: fasting plasma insulin; HOMA-IR: homeostasis model assessment insulin resistance; IGI: insulinogenic index; GTP: glucose tolerance phenotype; NGT: normal glucose tolerance; IFG: impaired fasting glucose; IGT: impaired glucose tolerance
- Insulinogenic index (IGI) was log-transformed before analysis. † Means and standard deviations; ‡ Frequencies and percentages. Model adjusted for diagnosis, BMI, sex, and age
- aSignificant effect of diagnosis (F = 4.365; p = .006; ŋ2 = 0.096), age (F = 11.961; p = .001; ŋ2 = 0.088), diagnosis*sex (F = 3.879; p = .011; ŋ2 = 0.086)
- bSignificant effect of diagnosis (F = 4.269; p = .007; ŋ2 = 0.094), BMI (F = 15.319; p = < .001; ŋ2 = 0.110), sex (F = 13.521; p = .001; ŋ2 = 0.098), age (F = 8.935; p = .003; ŋ2 = 0.067), diagnosis*sex (F = 4.649; p = .004; ŋ2 = 0.101)
- cSignificant effect of BMI (F = 14.452; p = < .001; ŋ2 = 0.104)
- dSignificant effect of diagnosis (F = 6.386; p < .001; ŋ2 = 0.134), BMI (F = 14.432; p < .001; ŋ2 = 0.104), sex (F = 9.476; p = .003; ŋ2 = 0.071), diagnosis*sex (F = 6.486; p < .001; ŋ2 = 0.136)
- eSignificant effect of age (F = 18.542; p < .001; ŋ2 = 0.130)